The safety and scientific validity of each study registered on the ANZCTR is the responsibility of the study sponsor and investigators. Listing a study on the ANZCTR does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to information for consumers

Number of records retrieved: 1

Page: 1 

Trial from ANZCTR

A pilot study to investigate the efficacy, feasibility and safety of once weekly injection of exenatide-LAR in addition to standard diabetes care on blood glucose control in indigenous Australians with type 2 diabetes living in remote communities

  • Recruitment status at the time of last update
  • What is the status of the ethics application?
    Ethics status: Approved
  • Prospective – trial registered prior to recruitment of first participant.

    Retrospective – trial registered after recruitment of first participant.
    Prospectively registered
  • Has the trial been updated in the last 12 months?
    Up to date
    (Last updated: 17/12/2018)
  • Ethics status: Approved
    What is the status of the ethics application?
  • Up to date
    Has the trial been updated in the last 6 months?
Key trial Information

Trial ID


Date registered

02 September 2015

Health condition

Type 2 Diabetes

Recruitment countries


Recruitment site location(s) (State)

Northern Territory

Recruitment status


Anticipated date of first participant enrolment

04 January 2016

Ethics application status


Brief summary

To demonstrate, as part of a pilot study, the feasibility and safety of a clinical trial to demonstrate the efficacy, safety and acceptability of a once weekly injection of exenatide LAR in addition to weekly clinical contact and otherwise usual care in Aboriginal Australians and/or Torres Strait Islanders (Indigenous Australians) with sub-optimally controlled type 2 diabetes.


Key inclusion criteria

Indigenous Australians with T2DM, BMI > 25kg/m2 and HbA1c > 7.5%.

Minimum age

18 Years

Maximum age

No limit


Both males and females

Key exclusion criteria

Pregnancy , childbearing potential, Type 1 diabetes, history of pancreatitis, history of heavy alcohol abuse, eGFR < 45 45ml/min/1.73m2

Contact details and further information

Primary Sponsor

Type: Other
Name: BakerIDI Heart and Diabetes Institute
Address: 75 Commercial Rd Melbourne , VIC 3004
Country: Australia

Contact person for information and recruitment

A/Prof Neale Cohen
BakerIDI Heart and Diabetes Institute
Level 4, 99 Commercial Rd , Melbourne